ABT-869 is an ATP-competitive, multi-targeted RTK inhibitor that is completely effective against all members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families.
Molecular Weight:
375.405
CAS Number:
[796967-16-3]
Formula:
C21H18FN5O
* VAT and and shipping costs not included. Errors and price changes excepted